指南证据发布与儿童难治性惊厥性癫痫持续状态治疗延迟的关联
该研究基于pSERG前瞻性数据集进行回顾性分析,比较2011—2014年与2015—2019年证据发布前后儿童难治性惊厥性癫痫持续状态的治疗时间。共纳入328例患者,结果发现至首次苯二氮䓬类、非苯二氮䓬类抗癫痫药物及持续输注的时间均无显著差异,但院前至少接受1次苯二氮䓬类的比例在证据发布后显著增加。
要点
- 证据发布后儿童rSE至首次BZD、非BZD抗癫痫药物及持续输注的时间未见显著缩短。
- 院前起病患者在到达医院前接受至少1次BZD的比例从50.6%升至75%,多因素OR为4.35。
- 证据传播本身未改善院内治疗时效,需配套流程改进。
核心结论
- 关于治疗延迟的证据发表与儿童rSE治疗时间改善无关,但与院前至少接受1次BZD的患者比例增加相关。
研究设计与样本
- 回顾性分析2011年6月至2019年9月pSERG前瞻性收集的数据集,纳入1月龄至21岁的儿童rSE患者,比较证据发表前(2011—2014年)与发表后(2015—2019年)的治疗时间。
主要发现
- 共纳入328例患者(56%男性),中位年龄3.8岁(p25-p75:1.3-9.4岁)。
- 至首次BZD的中位时间证据发表前为20分钟(p25-p75:5-52.5),发表后为15分钟(p25-p75:5-38),p=0.3919。
- 至首次非BZD抗癫痫药物的中位时间证据发表前为68分钟(p25-p75:34.5-163.5),发表后为65分钟(p25-p75:33-142),p=0.7328。
- 至首次持续输注的中位时间证据发表前为186分钟(p25-p75:124.2-571),发表后为160分钟(p25-p75:89.5-495),p=0.2236。
- 在157例院外起病且院前到达时间可得的患者中,院前至少接受1次BZD的比例证据发表前为41/81(50.6%),发表后为57/76(75%),p=0.0018;多因素logistic回归OR为4.35(95%CI 1.96-10.3),p=0.0005。
临床怎么用
- 证据发布未能缩短院内rSE治疗时间,提示需结合流程优化与质量改进措施。
- 院前BZD使用比例在证据发布后提高,可继续强化院前急救环节的早期干预。
局限性
- 本研究为回顾性分析,虽基于前瞻性收集的数据集,但可能存在混杂因素。
- 院前到达时间仅157例患者可得,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether publication of evidence on delays in time to treatment shortens time to treatment in pediatric refractory convulsive status epilepticus (rSE), we compared time to treatment before (2011-2014) and after (2015-2019) publication of evidence of delays in treatment of rSE in the Pediatric Status Epilepticus Research Group (pSERG) as assessed by patient interviews and record review. METHODS: We performed a retrospective analysis of a prospectively collected dataset from June 2011 to September 2019 on pediatric patients (1 month-21 years of age) with rSE. RESULTS: We studied 328 patients (56% male) with median (25th-75th percentile [p25-p75]) age of 3.8 (1.3-9.4) years. There were no differences in the median (p25-p75) time to first benzodiazepine (BZD) (20 [5-52.5] vs 15 [5-38] minutes, p = 0.3919), time to first non-BZD antiseizure medication (68 [34.5-163.5] vs 65 [33-142] minutes, p = 0.7328), and time to first continuous infusion (186 [124.2-571] vs 160 [89.5-495] minutes, p = 0.2236). Among 157 patients with out-of-hospital onset whose time to hospital arrival was available, the proportion who received at least 1 BZD before hospital arrival increased after publication of evidence of delays (41 of 81 [50.6%] vs 57 of 76 [75%], p = 0.0018), and the odds ratio (OR) was also increased in multivariable logistic regression (OR 4.35 [95% confidence interval 1.96-10.3], p = 0.0005). CONCLUSION: Publication of evidence on delays in time to treatment was not associated with improvements in time to treatment of rSE, although it was associated with an increase in the proportion of patients who received at least 1 BZD before hospital arrival.
引用
- Sánchez Fernández I, Abend NS, Amengual-Gual M, et al. Association of guideline publication and delays to treatment in pediatric status epilepticus. Neurology. 2020. PMID: 32611646. doi:10.1212/WNL.0000000000010174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。